Hyperthermia maka Tumor Ablation: Ọgwụgwọ Ọrịa Ọrịa Pancreatic na Nchọpụta

Ọrịa cancer pancreatic nwere ogo dị elu nke malignancy na prognosis na-adịghị mma.Na omume ụlọ ọgwụ, a na-achọpụta ọtụtụ ndị ọrịa na ọkwa dị elu, na-enwe ọnụ ọgụgụ ịwa ahụ dị ala na enweghị nhọrọ ọgwụgwọ pụrụ iche.The ojiji nke HIFU nwere ike n'ụzọ dị irè belata akpụ ibu, akara mgbu, si otú ịgbatị ndidi lanarị na mma àgwà nke ndụ.

Akụkọ banyere hyperthermian'ihi na etuto nwere ike ịchọtalaa azụ 5,000 afọ gara agan'Ijipt oge ochie, nke nwere ihe ndekọ na ihe odide ndị Ijipt oge ochie na-akọwa ijiokpomọkụ na-agwọ ọrịa ara ara.Onye nchoputa nkethermal ọgwụgwọ, Hippocrates, onye a na-ewere dị ka nna nke nkà mmụta ọgwụ n'Ebe Ọdịda Anyanwụ, biri ihe dị ka afọ 2,500 gara aga.

Hyperthermia bụ usoro ọgwụgwọ nke gụnyere itinye isi mmalite ọkụ dị iche iche(dị ka rediofrequency, microwave, ultrasound, laser, wdg.)iji mee ka okpomọkụ nke anụ ahụ tumor dịkwuo elu na ọkwa ọgwụgwọ dị irè.Mmụba okpomọkụ a na-eduga na ọnwụ nke mkpụrụ ndụ tumo ma na-ebelata mmebi nke mkpụrụ ndụ nkịtị.

Na 1985, US FDA kwadoro ịwa ahụ, ọgwụgwọ radieshon, chemotherapy, Hyperthermia, na immunotherapy dị ka.Ụzọ nke ise dị irè maka ọgwụgwọ tumor, na-anọchi anya ụzọ ọhụrụ ma dị irè.

Ụkpụrụ bụ isi bụ iji ike anụ ahụ mee ka ahụ dum kpoo ọkụ ma ọ bụ akụkụ ahụ kpọmkwem, na-eme ka ure na-ekpo ọkụ nke anụ ahụ na-eme ka ọ bụrụ ọkwa ọgwụgwọ dị irè ma na-edobe ya ruo oge ụfọdụ.Site n'iji ohere dị iche iche na nnabata okpomọkụ dị n'etiti anụ ahụ nkịtị na mkpụrụ ndụ tumor, ọ na-achọ imezu ebumnuche nke ịkpalite apoptosis tumor cell na-emebighị anụ ahụ nkịtị.

Usoro ọgwụgwọ ọrịa cancer pancreatic 1:

Onye ọrịa: nwanyị, 46 afọ, etuto na ọdụ ọdụ nke pancreas

Dayameta nke etuto ahụ tụrụ 34mm (anteroposterior), 39mm (transverse), na 25mm (craniocaudal).Site na usoro ọgwụgwọ thermal ablation nke na-eduzi ultrasound,MRI na-esochi na-ekpughe na ihe ka ọtụtụ n'ime ụbụrụ ahụ emebeghị.

Usoro ọgwụgwọ ọrịa cancer pancreatic 2:

Onye ọrịa: nwanyị, dị afọ 56, ọrịa kansa pancreatic nwere ọtụtụ metastases imeju

Ọgwụgwọ n'otu oge maka pancreatic na metastases nke imeju site na iji ọgwụgwọ ablation thermal na-eduzi ultrasound.MRI na-esochi gosipụtara arụghị ọrụ etuto ahụ, nwere oke doro anya na nke ziri ezi.

Usoro ọgwụgwọ ọrịa cancer pancreatic 3:

Onye ọrịa: Nwoke, 54 afọ, ọrịa kansa pancreatic

Mgbu kpamkpam n'ime ụbọchị 2mgbe HIFU (elu-ike lekwasịrị anya ultrasound) ọgwụgwọ.Akpụ ahụ mebiri site na 62.6% na izu 6, 90.1% na ọnwa 3, yana ọkwa CA199 laghachiri na nkịtị na ọnwa 12.

Usoro ọgwụgwọ ọrịa cancer pancreatic 4:

Onye ọrịa: nwanyị, 57 afọ, ọrịa kansa pancreatic

Tumor necrosis mere 3 ụbọchị mgbe ọgwụgwọ HIFU gasịrị.Akpụ ahụ kwụsịrị site na 28.7% na izu 6, 66% na ọnwa 3, na mgbu na-ebelata kpamkpam.

Usoro ọgwụgwọ ọrịa cancer pancreatic 5:

Onye ọrịa: nwanyị, 41 afọ, ọrịa kansa pancreatic

Mgbe ụbọchị 9 nke ọgwụgwọ HIFU gasịrị,nyocha PET-CT na-esochi gosipụtara necrosis buru ibu na etiti etuto ahụ.

Usoro ọgwụgwọ ọrịa cancer pancreatic 6:

Onye ọrịa: Nwoke, 69 afọ, ọrịa kansa pancreatic

Nyocha PET-CT na-esochi ọkara ọnwa mgbe ọgwụgwọ HIFU gasịrịkpughere kpamkpam efu nke etuto ahụ, enweghị nkwado FDG, yana mbelata na-esote na ọkwa CA199.

Usoro ọgwụgwọ ọrịa cancer pancreatic 7:

Onye ọrịa: nwanyị, 56 afọ, ọrịa kansa pancreatic

Nyocha CT na-esochi otu ụbọchị mgbe ọgwụgwọ HIFU gosipụtara80% ablation nke tumor.

Usoro ọgwụgwọ ọrịa cancer pancreatic 8:

57 afọ, ọrịa cancer pancreatic

Mgbe ọgwụgwọ HIFU gasịrị, nyocha CT na-esochikpughere ablation zuru oke na etiti etuto ahụ.